Banners-LP-Scale-up-your-screening_20230526v2

Increase throughput. Improve efficiency.

Fast and reliable screening is vital - whether you're looking to bring the next life-saving drug to market, make the next breakthrough discovery, or simply take your company to the next level. Automating your workflow increases your throughput, improves your efficiency, and produces the data you need quickly and reliably.

 

Select your area of expertise below to learn how automation can deliver on your goals.

To be ahead of the competition, you need higher throughput. An automated solution means you can process more samples, get more data, and move to market faster, while your highly-paid, expert staff can move away from menial, manual roles and focus on more important tasks.

Whether you're screening thousands of anti-cancer drugs or developing new cell models for the pharmaceutical industry, we can create a cost-effective solution that doesn't stop when your workforce does!

LEARN MORE

When you're just starting out, every penny is precious - but automation doesn't have to break the bank. Even a small increase in efficiency can quickly pay dividends. 

We can create an easy-to-use solution that's fast to implement, pays for itself quickly, and makes the best use of your existing setup—saving you valuable time and money!

LEARN MORE

Your research institute, college, or university's funding is reliant on publishing timely, impactful papers. Creating an automated screening system in your core facility can empower researchers from all across the institute (and beyond!) to perform more rigorous, cutting-edge experiments in an effort to get published faster.

We can work with you to create a flexible automation solution that will meet the various needs of your current researchers, but can evolve as your research does. 

LEARN MORE

While organoids hold great promise to transform basic research, drug development, and precision medicine, many major hurdles need to be overcome to realize the full potential of organoid medicine. We chose Molecular Devices to help solve these issues by developing fully automated high-throughput workflows for improved scalability, reproducibility of organoid production, and novel organoid-based drug screening platforms.

– Magdalena Kasendra, Ph.D.

Director of Research and Development, Center for Stem Cell & Organoid Medicine (CuSTOM) Accelerator at Cincinnati Children’s Hospital Medical Center (CCHMC)

How can we help?

We work with you to understand your goals, your science, and your need, and create a cost-effective, automated solution - including hardware, software, labware and robotics - which meets your needs and fits within your budget. 

We will support you across the entire journey - from throughput analysis, software and hardware customization, factory acceptance, site acceptance, validation testing and ongoing support. 

Let's Connect!

How we've helped customers like you

Screening System

Location: HCS Pharma

HCS Pharma creates innovative 3D cellular models which enable researchers to perform phenotypic screening on more relevant 3D cellular assays that also consider the extracellular matrix (ECM).

Today, HCS Pharma can perform high quality 3D cell assays in a high-throughput manner. With the implementation of their HAPIx platform, they now have a very powerful and fast tool that they can offer to customers from the pharmaceutical industry to perform high-throughput phenotypic screens on 3D cell models. This is in addition to the low/medium throughput assays that they already offered to the pharmaceutical, dermo-cosmetic and nutraceutical industries.

HCPharmaPicture1

Cell Biology Platform

Location: Kroemer Lab, Gustave Roussy Cancer Center

The Cell Biology platform within the Kroemer Lab is used as a hub to conduct screening approaches as it offers fully automated cell biology workflows that allow for the phenotypic screening of large-scale compound and siRNA libraries.

To enable this cutting-edge research, the group needed a high-content analysis system that they could fully integrate into an automated platform which also includes compound management and automated cell culture.

 

 
Kroemer LabPicture2

Mechano-medicine discovery screening

Location: Forcyte Biotechnologies

Forcyte Biotechnologies has integrated our imaging solutions with automated components to create a ssystem capable of screening 30,000 cell-drug combinations per day.

Forcyte Biotechnologies, Inc. is a drug discovery startup performing phenotypic screening of contractile cell force as a HTS assay endpoint. The company manufactures and utilizes unique microplates with soft-film bottoms embedded with fluorescent micropatterns to which thousands of cells simultaneously adhere and then contract (or squeeze). Optical measurements of micropattern contraction in the presence of drug provides functional data on whether a drug modulates cellular force generation, enabling discovery of novel mechano-modulating medicine (mechano-medicine).

forcyte-biotechnologies-1

Organoid Innovation Center (OIC)

Location: Molecular Devices

Modular, automated 3D cell culture and image analysis lab enables customers to streamline and scale organoid interrogation, advancing drug discovery research

 

The Organoid Innovation Center at Molecular Devices combines cutting-edge technologies with novel 3D biology methods to address key challenges of scaling complex 3D biology.

An end-to-end solution standardizes the organoid development process with cell culture, treatment, and incubation, through to imaging, analysis, and data processing, delivering consistent, unbiased, and biologically-relevant results at scale.

OIC Pic_20220928